Research: Rethinking mastitis treatment to improve costs and health
Following minimum labelled duration for mastitis drugs is critical to farm cost savings and productivity, as well as maintaining animal and human health.
Following minimum labelled duration for mastitis drugs is critical to farm cost savings and productivity, as well as maintaining animal and human health.
A key to maintaining the demand for dairy is to continue sending positive messages to consumers about U.S. milk production and milk quality.
National Mastitis Council named Andrew (Andy) Johnson as the 2019 NMC Award of Excellence for Contribution to Mastitis Prevention and Control recipient.
AgriLabs has announced the commercialization of KLEBVax SRP, the first vaccine licensed for dairy cattle to prevent mastitis caused by Klebsiella pneumoniae. KLEBVax SRP, which features Siderophore Receptor and Porin (SRP) technology, gives veterinarians and producers a new tool to prevent disease and reduce antibiotic use. A similar vaccine using Klebsiella SRP bacterial extract was […]
It is estimated that mastitis costs the U.S. dairy industry $2 billion each year. However, most dairy producers might not realize only 15 percent of cases need to be treated immediately and systematically. Eighty-five percent of cases are actually mild or moderate, and delaying treatment 24 to 36 hours won’t change the outcome. “Most of […]
Dairies can now cancel out mastitis through electromagnetic frequency. Aspen Veterinary Resources recently introduced a new product line of stall and feed additives, that reduces mastitis in dairy cows, through a technology similar to noise-cancelling headphones. The first of its kind in the United States, Easy Cow and Gold Pro Cow, are made with all-natural […]